Quick Answer
Bionano Genomics, Inc. reported Total Revenue of $28.51 million for the year ending 2025.
- Bionano Genomics, Inc. showed a decrease of -7.4% in Total Revenue from 2024 to 2025.
- This data is from Bionano Genomics, Inc.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $1.72 million | Q2 2017: $2.20 million | Q3 2017: $2.74 million | Q3 2017: $2.74 million | Q4 2017: $2.85 million | Q1 2018: $1.77 million | Q1 2018: $1.77 million | Q2 2018: $3.39 million | Q2 2018: $3.39 million | Q3 2018: $2.83 million | Q3 2018: $2.83 million | Q4 2018: $4.01 million | Q4 2018: $4.01 million | Q1 2019: $1.85 million | Q2 2019: $2.18 million | Q3 2019: $3.31 million | Q4 2019: $2.79 million | Q1 2020: $1.14 million | Q2 2020: $1.18 million | Q3 2020: $2.20 million | Q1 2021: $3.17 million | Q2 2021: $3.86 million | Q3 2021: $4.66 million | Q1 2022: $5.70 million | Q2 2022: $6.67 million | Q3 2022: $7.22 million | Q1 2023: $7.42 million | Q2 2023: $8.66 million | Q3 2023: $9.32 million | Q1 2024: $8.77 million | Q2 2024: $7.77 million | Q3 2024: $6.07 million | Q1 2025: $6.46 million | Q2 2025: $6.73 million | Q3 2025: $7.37 million.
- Over the full 10 years of available data (2017 to 2025), Bionano Genomics, Inc.'s Total Revenue has grown by 199.9%.
- Historical annual values: Fiscal year 2025: $28.51 million | Fiscal year 2024: $30.78 million | Fiscal year 2023: $36.12 million | Fiscal year 2022: $27.80 million | Fiscal year 2021: $17.98 million | Fiscal year 2020: $8.50 million | Fiscal year 2019: $10.13 million | Fiscal year 2018: $12.00 million | Fiscal year 2018: $12.00 million | Fiscal year 2017: $9.51 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: